1 |
-aminosalicylic acid |
Aminosalicylic acid |
1件: D00162 D00162 💬 |
- |
- |
096 2件: 96, 97 💬 |
2 |
0,25 mg rpc1063 |
- |
- |
- |
- |
096 1件: 96 💬 |
3 |
0.25 mg rpc1063 |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
4 |
0114-0006b |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
5 |
10 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
6 |
10% metronidazole ointment |
Metronidazole |
3件: D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
096 1件: 96 💬 |
7 |
1000 iu d3 |
- |
- |
- |
- |
096 1件: 96 💬 |
8 |
13-valent pneumococcal conjugated vaccine (pcv13) |
- |
- |
- |
- |
096 1件: 96 💬 |
9 |
18f-fdg |
Fludeoxyglucose (18F) |
- |
- |
- |
005 12件: 5 , 6 , 7 , 13, 41, 46, 53, 84, 85, 96, 127, 300 💬 |
10 |
1mg rpc1063 |
- |
- |
- |
- |
096 1件: 96 💬 |
11 |
2'-fucosyllactose |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
12 |
23-valent polysaccharide pneumococcal vaccine |
- |
- |
- |
- |
096 1件: 96 💬 |
13 |
23-valent polysaccharide pneumococcal vaccine (pneumovax tm) |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
14 |
25 mg ontamalimab |
Ontamalimab |
- |
- |
- |
096 2件: 96, 97 💬 |
15 |
3-hydroxy-2-methyl-4h-pyrane-4-one iron (iii) complex (3:1), ferric (3-hydroxy-2-methyl-4-pyrone), tris-maltol-iron (iii), tri=maltol-iron (iii) |
Tromethamine |
1件: D00396 D00396 💬 |
- |
- |
096 2件: 96, 97 💬 |
16 |
331731-18-1 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
17 |
4-aminosalicylic acid |
Aminosalicylic acid |
1件: D00162 D00162 💬 |
- |
- |
096 1件: 96 💬 |
18 |
4-aminosalicylic acid extended release granules |
Aminosalicylic acid |
1件: D00162 D00162 💬 |
- |
- |
096 1件: 96 💬 |
19 |
40 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
20 |
40 mg msb11022 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
21 |
42942019 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
22 |
5-aminolevulinic acid |
Aminolevulinic acid |
2件: D02908 D02908, D07567 D07567 💬 |
- |
- |
096 1件: 96 💬 |
23 |
5-aminosalicyl acid |
- |
- |
- |
- |
096 1件: 96 💬 |
24 |
5-aminosalicylate (pentasa, ferring) |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
25 |
5-aminosalicylic acid |
Aminosalicylic acid |
2件: D00162 D00162, D00377 D00377 💬 |
- |
- |
096 2件: 96, 97 💬 |
26 |
5-asa |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 2件: 96, 97 💬 |
27 |
5-htp |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
28 |
5000 iu d3 |
- |
- |
- |
- |
096 1件: 96 💬 |
29 |
549-0261/f02-01 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
30 |
6 mercaptopurine |
Mercaptopurine |
2件: D00161 D00161, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 2件: 96, 97 💬 |
31 |
6-[(methyl-4-nitro-1h-imidazol-5-yl)thio]-1h-purine |
- |
- |
- |
- |
096 1件: 96 💬 |
32 |
6-mercaptopurine |
Mercaptopurine |
2件: D00161 D00161, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 3件: 96, 97, 164 💬 |
33 |
6-mercaptopurine (puri-nethol) |
Mercaptopurine |
2件: D00161 D00161, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 1件: 96 💬 |
34 |
6-mp |
Mercaptopurine |
2件: D00161 D00161, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 2件: 96, 97 💬 |
35 |
683699 |
- |
- |
- |
- |
096 1件: 96 💬 |
36 |
75 mg ontamalimab |
Ontamalimab |
- |
- |
- |
096 2件: 96, 97 💬 |
37 |
80 mg dr-6mp |
- |
- |
- |
- |
096 1件: 96 💬 |
38 |
99mtc-s-hynic certolizumab pegol |
Certolizumab pegol |
1件: D03441 D03441 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 2件: 46, 96 💬 |
39 |
?-3 polyunsaturated fatty acid |
- |
- |
- |
- |
096 1件: 96 💬 |
40 |
[124i]ib pf 06687234 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
41 |
[14c]-rpc1063 solution (0.1 mg/ml) for oral administration |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
42 |
[18f]fspg |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
43 |
[cx601] |
- |
- |
- |
- |
096 1件: 96 💬 |
44 |
[ops-2071] |
- |
- |
- |
- |
096 1件: 96 💬 |
45 |
[rpc0163] |
- |
- |
- |
- |
096 1件: 96 💬 |
46 |
[rpc1063] |
- |
- |
- |
- |
096 1件: 96 💬 |
47 |
A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine |
Clarithromycin |
3件: D00276 D00276, D00278 D00278, D00424 D00424 💬 |
- |
- |
096 1件: 96 💬 |
48 |
A-1293543.74 |
- |
- |
- |
- |
096 1件: 96 💬 |
49 |
Ab1010 |
- |
- |
- |
- |
002 6件: 2 , 5 , 6 , 13, 46, 96 💬 |
50 |
Abatacept |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
51 |
Abbv-066 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
52 |
Abr-215062 sodium salt |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
53 |
Abrilumab |
Abrilumab |
1件: D10540 D10540 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 2件: 96, 97 💬 |
54 |
Abt 494 12mg |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
55 |
Abt 494 3mg |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
56 |
Abt humira |
- |
- |
- |
- |
096 1件: 96 💬 |
57 |
Abt-494 |
- |
- |
- |
- |
041 6件: 41, 46, 49, 96, 97, 271 💬 |
58 |
Abt-874 |
- |
- |
- |
- |
096 1件: 96 💬 |
59 |
Abx464 |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
60 |
Accelerated 1 hour-infusion |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
61 |
Accelerated 30 minutes-infusion |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
62 |
Acetaminophen |
Acetaminophen |
1件: D00217 D00217 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
011 14件: 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬 |
63 |
Acetate |
Acetate |
- |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
64 |
Adalimumab |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
019 16件: 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬 |
65 |
Adalimumab (40 mg) |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
66 |
Adalimumab (d2e7) |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 271 💬 |
67 |
Adalimumab 40 mg eow or ew |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
68 |
Adalimumab and infliximab |
Adalimumab |
2件: D02597 D02597, D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
69 |
Adalimumab injection |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 2件: 46, 96 💬 |
70 |
Adalimumab prn |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
71 |
Adsvf |
- |
- |
- |
- |
096 1件: 96 💬 |
72 |
Adult human mesenchymal stem cells |
Remestemcel-L |
1件: D09719 D09719 💬 |
- |
- |
085 2件: 85, 96 💬 |
73 |
Agri-king synbiotic (aksb) |
- |
- |
- |
- |
096 1件: 96 💬 |
74 |
Ain457 |
- |
- |
- |
- |
013 7件: 13, 37, 41, 46, 56, 96, 271 💬 |
75 |
Albendazole |
Albendazole |
1件: D00134 D00134 💬 |
- |
- |
096 1件: 96 💬 |
76 |
Albendazole (eskazole) |
Albendazole |
1件: D00134 D00134 💬 |
- |
- |
096 1件: 96 💬 |
77 |
Albumen |
Egg white |
- |
- |
- |
096 1件: 96 💬 |
78 |
Albumine humaine |
- |
- |
- |
- |
096 1件: 96 💬 |
79 |
Aldesleukin |
Aldesleukin |
1件: D00748 D00748 💬 |
IL2RA 3件: IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction 14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
049 4件: 49, 65, 96, 97 💬 |
80 |
Alemtuzumab |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 16件: 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
81 |
Alequel |
- |
- |
- |
- |
096 1件: 96 💬 |
82 |
Alfacalcidol |
Alfacalcidol |
1件: D01518 D01518 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
041 6件: 41, 46, 49, 50, 96, 235 💬 |
83 |
Alicaforsen |
Alicaforsen |
- |
- |
- |
096 2件: 96, 97 💬 |
84 |
Alicalm (polymeric liquid formula) |
- |
- |
- |
- |
096 1件: 96 💬 |
85 |
Allo-asc |
- |
- |
- |
- |
096 1件: 96 💬 |
86 |
Allo-asc-cd |
- |
- |
- |
- |
096 1件: 96 💬 |
87 |
Allogeneic bone marrow derived human mesenchymal stem cells (hmscs) |
- |
- |
- |
- |
096 1件: 96 💬 |
88 |
Allogeneic stem cell therapy |
- |
- |
- |
- |
096 1件: 96 💬 |
89 |
Allogenic eascs 5 milion cells/ml suspension for injection. cx601 |
- |
- |
- |
- |
096 1件: 96 💬 |
90 |
Allogenic eascs 5 million cells/ml suspension for injection cx601 |
- |
- |
- |
- |
096 1件: 96 💬 |
91 |
Allogenic eascs 5 million cells/ml suspension for injection. cx601 |
- |
- |
- |
- |
096 1件: 96 💬 |
92 |
Allogenic eascs 5 million/ml suspension for injection. |
- |
- |
- |
- |
096 1件: 96 💬 |
93 |
Allopurinol |
Allopurinol |
1件: D00224 D00224 💬 |
XDH 1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
006 6件: 6 , 46, 57, 66, 96, 97 💬 |
94 |
Allopurinol sandoz 100 mg, tabletten |
Allopurinol |
1件: D00224 D00224 💬 |
XDH 1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
096 1件: 96 💬 |
95 |
Allopurinol sodium |
Allopurinol |
1件: D00224 D00224 💬 |
XDH 1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
096 1件: 96 💬 |
96 |
Alofisel |
- |
- |
- |
- |
096 1件: 96 💬 |
97 |
Alx-0600 |
- |
- |
- |
- |
096 1件: 96 💬 |
98 |
Amg 139 |
- |
- |
- |
- |
096 1件: 96 💬 |
99 |
Amg 181 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
100 |
Amg 827 |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
101 |
Amg 827 210 mg |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
102 |
Amg 827 350 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
103 |
Amg 827 700 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
104 |
Amgevita |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
105 |
Amgevita (adalimumab biosimilar ) |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
106 |
Amgevita 40 mg injektionslösung im fertigpen |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
107 |
Amgevita 40 mg injektionslösung in einer fertigspritze |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
108 |
Amgevita 40mg solution for injection |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
109 |
Amgevita® |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
110 |
Aminolevulinic acid |
Aminolevulinic acid |
2件: D02908 D02908, D07567 D07567 💬 |
- |
- |
034 3件: 34, 96, 286 💬 |
111 |
Aminosalicylic acid |
Aminosalicylic acid |
1件: D00162 D00162 💬 |
- |
- |
096 2件: 96, 97 💬 |
112 |
Ammonium chloride |
Ammonium chloride |
1件: D01139 D01139 💬 |
- |
- |
096 1件: 96 💬 |
113 |
Amoxicillin |
Amoxicillin |
3件: D00229 D00229, D02925 D02925, D07452 D07452 💬 |
- |
- |
006 7件: 6 , 46, 63, 96, 97, 222, 299 💬 |
114 |
An100226 |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
115 |
Andecaliximab |
- |
- |
- |
- |
046 4件: 46, 96, 97, 299 💬 |
116 |
Andosan |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
117 |
Anti tnf |
- |
- |
- |
- |
096 1件: 96 💬 |
118 |
Anti tnf alfa. |
- |
- |
- |
- |
096 1件: 96 💬 |
119 |
Anti tnf humanized antibody fab fragment-peg conjugate |
- |
- |
- |
- |
096 1件: 96 💬 |
120 |
Anti tnf therapy including infliximab |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
121 |
Anti-cd3 |
Muromonab |
1件: D05092 D05092 💬 |
CD3D 3件: CD3D, CD3E, CD3G 💬 |
Chagas disease 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 2件: 96, 97 💬 |
122 |
Anti-cd3 monoclonal antibody |
Muromonab |
1件: D05092 D05092 💬 |
CD3D 3件: CD3D, CD3E, CD3G 💬 |
Chagas disease 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 2件: 96, 97 💬 |
123 |
Anti-il-12 |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
124 |
Anti-il-23 monoclonal antibody |
- |
- |
- |
- |
096 1件: 96 💬 |
125 |
Anti-il-6 mab |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
126 |
Anti-interferon-gamma monoclonal antibody |
- |
- |
- |
- |
096 1件: 96 💬 |
127 |
Anti-interleukin-23 immunoglobulin g2 (igg2) human |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
128 |
Anti-interleukin-23 immunoglobulin g2 (igg2) human monoclonal antibody |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
129 |
Anti-interleukin-6 monoclonal antibody |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
130 |
Anti-madcam antibody |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
131 |
Anti-thymocyte globulin (rabbit) |
Rabbit |
- |
- |
- |
060 4件: 60, 65, 96, 285 💬 |
132 |
Anti-tnf |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
133 |
Anti-tnf discontinuation: physiological saline solution |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
134 |
Anti-tnf drug |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
135 |
Anti-tnf therapy |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
136 |
Anti-tnf: infliximab (infusion) |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
137 |
Anti-tnf:adalimumab (subcutaneus) |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
138 |
Anticorpo monoclonale anti il-23 |
- |
- |
- |
- |
096 1件: 96 💬 |
139 |
Anticorpo monoclonale anti-il-23 |
- |
- |
- |
- |
096 1件: 96 💬 |
140 |
Antithymocyte immunoglobulin |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 2件: 13, 96 💬 |
141 |
Antithymocyte immunoglobulin (rabbit) |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 2件: 13, 96 💬 |
142 |
Apd334 |
- |
- |
- |
- |
093 4件: 93, 96, 97, 269 💬 |
143 |
Apd371 |
- |
- |
- |
- |
096 1件: 96 💬 |
144 |
Apixaban |
Apixaban |
1件: D03213 D03213 💬 |
F10 1件: F10 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
096 3件: 96, 97, 222 💬 |
145 |
Apixaban 2.5 milligram |
Apixaban |
1件: D03213 D03213 💬 |
F10 1件: F10 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
096 2件: 96, 97 💬 |
146 |
Application of adalimumab |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
147 |
Ar401959 l-arginine |
Arginine |
1件: D02982 D02982 💬 |
- |
- |
096 2件: 96, 97 💬 |
148 |
Arginine |
Arginine |
1件: D02982 D02982 💬 |
- |
- |
046 9件: 46, 67, 78, 96, 97, 113, 210, 251, 299 💬 |
149 |
As |
- |
- |
- |
- |
046 6件: 46, 53, 96, 97, 215, 271 💬 |
150 |
Asa |
- |
- |
- |
- |
013 4件: 13, 96, 97, 251 💬 |
151 |
Asc |
- |
- |
- |
- |
036 4件: 36, 51, 96, 97 💬 |
152 |
Ascs |
- |
- |
- |
- |
053 2件: 53, 96 💬 |
153 |
Ascs: adipose derived stem cells |
- |
- |
- |
- |
096 1件: 96 💬 |
154 |
Ast-120 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
155 |
Atg |
- |
- |
- |
- |
013 4件: 13, 60, 96, 285 💬 |
156 |
Atorvastatin |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
157 |
Autologous adipose derived stromal vascular fraction |
- |
- |
- |
- |
096 1件: 96 💬 |
158 |
Autologous cd34-selected peripheral blood stem cells transplant |
- |
- |
- |
- |
096 1件: 96 💬 |
159 |
Autologous mesenchymal stromal cell |
- |
- |
- |
- |
096 2件: 96, 298 💬 |
160 |
Autologous ovalbumin-specific type 1 regulatory t lymphocytes expanded population |
- |
- |
- |
- |
096 1件: 96 💬 |
161 |
Autologous stem cell transplantation |
- |
- |
- |
- |
056 2件: 56, 96 💬 |
162 |
Aza |
- |
- |
- |
- |
011 4件: 11, 40, 96, 97 💬 |
163 |
Azathioprin |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
164 |
Azathioprin-ratiopharm 25 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
165 |
Azathioprin-ratiopharm 25mg filmtabletten |
- |
- |
- |
- |
096 1件: 96 💬 |
166 |
Azathioprin-ratiopharm 50 mg filmtabletten |
- |
- |
- |
- |
096 1件: 96 💬 |
167 |
Azathioprine |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
006 20件: 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
168 |
Azathioprine (aza) caps |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
096 1件: 96 💬 |
169 |
Azathioprine (aza) or 6-mercaptopurine (6-mp) |
Azathioprine |
4件: D00161 D00161, D00238 D00238, D03033 D03033, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 2件: 96, 97 💬 |
170 |
Azathioprine - ratiopharm 50 mg |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
096 1件: 96 💬 |
171 |
Azathioprine / 6 mercaptopurine |
Azathioprine |
4件: D00161 D00161, D00238 D00238, D03033 D03033, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 1件: 96 💬 |
172 |
Azathioprine in case of endoscopic recurrence |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
096 1件: 96 💬 |
173 |
Azathioprine individualised dose |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
096 1件: 96 💬 |
174 |
Azathioprine or 6-mercaptopurine |
Azathioprine |
4件: D00161 D00161, D00238 D00238, D03033 D03033, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 2件: 96, 97 💬 |
175 |
Azathioprine or adalimumab and infliximab |
Adalimumab |
4件: D00238 D00238, D02597 D02597, D02598 D02598, D03033 D03033 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
176 |
Azathioprine or mesalazine |
Azathioprine |
3件: D00238 D00238, D00377 D00377, D03033 D03033 💬 |
- |
- |
096 1件: 96 💬 |
177 |
Azathioprine or methotrexate |
Azathioprine |
4件: D00142 D00142, D00238 D00238, D02115 D02115, D03033 D03033 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
096 1件: 96 💬 |
178 |
Azathioprine weight-based dose |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
096 1件: 96 💬 |
179 |
Azathioprine+enteral nutrition |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
096 1件: 96 💬 |
180 |
Azatioprina |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
013 3件: 13, 96, 97 💬 |
181 |
Azd9056 |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
182 |
Azithromycin |
Azithromycin |
3件: D02134 D02134, D06390 D06390, D07486 D07486 💬 |
- |
- |
013 6件: 13, 84, 85, 96, 228, 299 💬 |
183 |
Azithromycin + metronidazole |
Azithromycin |
6件: D00409 D00409, D02134 D02134, D05016 D05016, D05017 D05017, D06390 D06390, D07486 D07486 💬 |
- |
- |
096 1件: 96 💬 |
184 |
B. theta |
- |
- |
- |
- |
096 1件: 96 💬 |
185 |
Bacteriophage preparation |
- |
- |
- |
- |
096 1件: 96 💬 |
186 |
Bacteriotherapy |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
187 |
Bean |
Bean |
- |
- |
- |
096 1件: 96 💬 |
188 |
Behavioral: abbvie care 2.0 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
189 |
Behavioral: diet counseling |
- |
- |
- |
- |
096 1件: 96 💬 |
190 |
Behavioral: dyadic psychological support (dps) |
- |
- |
- |
- |
096 1件: 96 💬 |
191 |
Behavioral: hypnosis |
- |
- |
- |
- |
096 1件: 96 💬 |
192 |
Behavioral: tip / impact plus care coordination |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
193 |
Beta carotene |
Beta carotene |
1件: D03101 D03101 💬 |
- |
- |
096 1件: 96 💬 |
194 |
Beta carotene from dunaliella algae |
Beta carotene |
1件: D03101 D03101 💬 |
- |
- |
096 1件: 96 💬 |
195 |
Betamethasone |
Betamethasone |
7件: D00244 D00244, D00972 D00972, D01357 D01357, D01402 D01402, D01637 D01637, D02032 D02032, D02286 D02286 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 6件: 2 , 28, 46, 90, 96, 235 💬 |
196 |
Bezlotoxumab |
Bezlotoxumab |
1件: D10453 D10453 💬 |
- |
- |
096 2件: 96, 97 💬 |
197 |
Bfahf-2 |
- |
- |
- |
- |
096 1件: 96 💬 |
198 |
Bi 655066 |
- |
- |
- |
- |
096 2件: 96, 271 💬 |
199 |
Bi 655066 10 mg/ml |
- |
- |
- |
- |
096 1件: 96 💬 |
200 |
Bi 655066 90 mg/ml |
- |
- |
- |
- |
096 2件: 96, 271 💬 |
201 |
Bi 655130 |
- |
- |
- |
- |
037 3件: 37, 96, 97 💬 |
202 |
Bi 695501 |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
203 |
Bibr 796 bs, 20 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
204 |
Bibr 796 bs, 5 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
205 |
Bifidobacterium infantis |
Bifidobacterium longum infantis |
- |
- |
- |
096 2件: 96, 97 💬 |
206 |
Bifidobacterium infantis 35624 |
Bifidobacterium longum infantis |
- |
- |
- |
096 2件: 96, 97 💬 |
207 |
Biological samplings |
- |
- |
- |
- |
096 1件: 96 💬 |
208 |
Biosimilar |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
209 |
Biosimilar infliximab |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 96, 97 💬 |
210 |
Bleomycin |
Bleomycin |
3件: D02177 D02177, D03229 D03229, D07535 D07535 💬 |
- |
- |
096 4件: 96, 278, 279, 280 💬 |
211 |
Bli-1300 high dose |
- |
- |
- |
- |
096 1件: 96 💬 |
212 |
Bli-1300 low dose |
- |
- |
- |
- |
096 1件: 96 💬 |
213 |
Blood and stools samples |
- |
- |
- |
- |
096 1件: 96 💬 |
214 |
Blood sampling |
- |
- |
- |
- |
013 5件: 13, 17, 19, 51, 96 💬 |
215 |
Bms-188667 |
- |
- |
- |
- |
046 8件: 46, 49, 53, 65, 96, 97, 222, 271 💬 |
216 |
Bms-936557 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
217 |
Bms-936557 (anti-ip-10 antibody) |
- |
- |
- |
- |
096 1件: 96 💬 |
218 |
Bms-945429 |
Clazakizumab |
1件: D10312 D10312 💬 |
- |
- |
046 2件: 46, 96 💬 |
219 |
Bms-986165 |
- |
- |
- |
- |
049 3件: 49, 96, 97 💬 |
220 |
Bms986165 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
221 |
Bone marrow derived mesenchymal stem cells (mscs) |
- |
- |
- |
- |
096 1件: 96 💬 |
222 |
Boulardii |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
223 |
Brazikumab |
Brazikumab |
1件: D10912 D10912 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 2件: 96, 97 💬 |
224 |
Brazikumab high dose |
Brazikumab |
1件: D10912 D10912 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
225 |
Brazikumab iv infusion |
Brazikumab |
1件: D10912 D10912 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
226 |
Brazikumab low dose |
Brazikumab |
1件: D10912 D10912 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
227 |
Brazikumab sc injection |
Brazikumab |
1件: D10912 D10912 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
228 |
Bt-11 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
229 |
Bt-11 1,000 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
230 |
Bt-11 1000mg |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
231 |
Bt-11 500 mg |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
232 |
Bt-11 active |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
233 |
Budenofalk |
- |
- |
- |
- |
096 1件: 96 💬 |
234 |
Budenofalk 3mg gastro-resistant capsules |
- |
- |
- |
- |
096 1件: 96 💬 |
235 |
Budenofalk 9mg gastro-resistant granules |
- |
- |
- |
- |
096 1件: 96 💬 |
236 |
Budesonide |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 9件: 66, 93, 94, 95, 96, 97, 98, 228, 299 💬 |
237 |
Budesonide ( zentacort capsules 3mg ) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
238 |
Bupivacaine |
Bupivacaine |
2件: D01450 D01450, D07552 D07552 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
046 8件: 46, 51, 53, 70, 96, 168, 226, 298 💬 |
239 |
Bupivacaine/epinephrine/dexamethasone |
Bupivacaine |
14件: D00095 D00095, D00292 D00292, D00975 D00975, D00996 D00996, D01450 D01450, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02149 D02149, D02174 D02174, D02591 D02591, D02592 D02592, D07552 D07552 💬 |
ADRA1A 15件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway 15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 1件: 96 💬 |
240 |
Bupropion |
Bupropion |
3件: D00817 D00817, D07591 D07591, D07938 D07938 💬 |
SLC6A2 2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
008 5件: 8 , 18, 21, 96, 171 💬 |
241 |
By demand |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
242 |
C326, il-6 inhibitory avimer protein |
- |
- |
- |
- |
096 1件: 96 💬 |
243 |
Caffeine |
Caffeine |
2件: D00528 D00528, D01453 D01453 💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 9件: 2 , 6 , 13, 21, 46, 78, 96, 97, 265 💬 |
244 |
Caffeine 100 mg |
Caffeine |
2件: D00528 D00528, D01453 D01453 💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 2件: 96, 97 💬 |
245 |
Calcitonin nasal spray (salmon) |
Salmon, unspecified |
- |
- |
- |
096 2件: 96, 97 💬 |
246 |
Calcitriol |
Calcitriol |
1件: D00129 D00129 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
037 8件: 37, 46, 49, 66, 96, 158, 235, 326 💬 |
247 |
Calcium |
Calcium |
- |
- |
- |
006 27件: 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
248 |
Calcium carbonate |
Calcium |
2件: D00932 D00932, D10802 D10802 💬 |
- |
- |
013 8件: 13, 19, 46, 53, 75, 96, 235, 299 💬 |
249 |
Caltrate pill |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
250 |
Cannabidiol |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 17件: 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬 |
251 |
Cannabidiol , synthetic form |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
096 1件: 96 💬 |
252 |
Cannabis |
Medical Cannabis |
- |
- |
- |
002 8件: 2 , 6 , 13, 46, 90, 96, 97, 271 💬 |
253 |
Cannabis, medical |
Medical Cannabis |
- |
- |
- |
002 5件: 2 , 6 , 13, 96, 97 💬 |
254 |
Carbon |
Activated charcoal |
1件: D03251 D03251 💬 |
- |
- |
006 9件: 6 , 46, 50, 51, 85, 86, 96, 97, 298 💬 |
255 |
Carbonate |
Carbonate ion |
- |
- |
- |
002 12件: 2 , 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
256 |
Carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 8件: 5 , 13, 58, 96, 97, 265, 298, 316 💬 |
257 |
Cc |
- |
- |
- |
- |
013 13件: 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 162, 202, 271 💬 |
258 |
Cc-5013 |
- |
- |
- |
- |
028 2件: 28, 96 💬 |
259 |
Ccx282-b |
- |
- |
- |
- |
096 1件: 96 💬 |
260 |
Cd |
- |
- |
- |
- |
006 6件: 6 , 46, 51, 96, 97, 265 💬 |
261 |
Cdp6038 |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
262 |
Cdp870 |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
263 |
Celebrex |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
264 |
Cellulose |
Microcrystalline cellulose |
1件: D00093 D00093 💬 |
- |
- |
035 4件: 35, 53, 96, 162 💬 |
265 |
Certican |
- |
- |
- |
- |
067 4件: 67, 96, 158, 228 💬 |
266 |
Certolizumab |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
267 |
Certolizumab pegol |
Certolizumab pegol |
1件: D03441 D03441 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
037 6件: 37, 46, 96, 97, 226, 271 💬 |
268 |
Certolizumab pegol (cdp870) |
Certolizumab pegol |
1件: D03441 D03441 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 2件: 46, 96 💬 |
269 |
Certolizumab pegol (cdp870, czp) |
Certolizumab pegol |
1件: D03441 D03441 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
270 |
Certolizumab pegol (czp) |
Certolizumab pegol |
1件: D03441 D03441 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 96, 271 💬 |
271 |
Certolizumab pegol (rinn) |
Certolizumab pegol |
1件: D03441 D03441 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
272 |
Certolizumab pegol /cimzia |
Certolizumab pegol |
1件: D03441 D03441 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
273 |
Certolizumab pegol 400 mg |
Certolizumab pegol |
1件: D03441 D03441 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
274 |
Chadox2 hav |
- |
- |
- |
- |
096 1件: 96 💬 |
275 |
Chenodeoxycholic acid |
Chenodeoxycholic acid |
1件: D00163 D00163 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
020 4件: 20, 96, 234, 263 💬 |
276 |
Chenodiol |
Chenodeoxycholic acid |
1件: D00163 D00163 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
096 1件: 96 💬 |
277 |
Chenofalk |
- |
- |
- |
- |
096 1件: 96 💬 |
278 |
Chimeric igg1 monoclonal antibody |
- |
- |
- |
- |
096 1件: 96 💬 |
279 |
Chloride |
Chloride ion |
- |
- |
- |
006 25件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
280 |
Chlorure de sodium |
- |
- |
- |
- |
096 1件: 96 💬 |
281 |
Cholecalciferol |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 9件: 13, 19, 34, 46, 49, 96, 97, 298, 299 💬 |
282 |
Cholecalciferol 10,000 iu |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 1件: 96 💬 |
283 |
Cholecalciferol 400 iu |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 1件: 96 💬 |
284 |
Cholecalciferol concentrate |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 1件: 96 💬 |
285 |
Cholecalciferol concentrate (water-dispersible form) |
Cholecalciferol |
2件: D00001 D00001, D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 1件: 96 💬 |
286 |
Cholestagel |
- |
- |
- |
- |
096 1件: 96 💬 |
287 |
Chondroitin sulfate |
Chondroitin sulfate |
1件: D00080 D00080 💬 |
- |
- |
096 2件: 96, 226 💬 |
288 |
Cimzia |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
289 |
Cimzia 200 mg solution for injection |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
290 |
Ciprofloxacin |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
002 5件: 2 , 60, 96, 97, 299 💬 |
291 |
Ciprofloxacin hydrochloride |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
096 2件: 96, 299 💬 |
292 |
Clarithromycin |
Clarithromycin |
1件: D00276 D00276 💬 |
- |
- |
006 8件: 6 , 63, 84, 96, 97, 222, 228, 299 💬 |
293 |
Clofarabine |
Clofarabine |
1件: D03546 D03546 💬 |
POLA1 3件: POLA1, POLA2, RRM1 💬 |
DNA replication 6件: DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
019 9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 💬 |
294 |
Clofazimine |
Clofazimine |
1件: D00278 D00278 💬 |
- |
- |
096 1件: 96 💬 |
295 |
Cnto 1275 |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
296 |
Cnto1275 |
- |
- |
- |
- |
046 6件: 46, 49, 84, 93, 96, 97 💬 |
297 |
Cnto1959 |
- |
- |
- |
- |
037 3件: 37, 96, 97 💬 |
298 |
Coffee |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
299 |
Colecalciferol |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 4件: 13, 46, 96, 228 💬 |
300 |
Colecalciferol d3 (vigantol oil) |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 1件: 96 💬 |
301 |
Colesevelam |
Colesevelam |
2件: D03582 D03582, D07743 D07743 💬 |
- |
- |
096 2件: 96, 260 💬 |
302 |
Colony-purified bacteroides thetaiotaomicron (b.theta) |
- |
- |
- |
- |
096 1件: 96 💬 |
303 |
Contrast enhanced ultrasound |
- |
- |
- |
- |
096 1件: 96 💬 |
304 |
Cortecosteroid |
- |
- |
- |
- |
096 1件: 96 💬 |
305 |
Corticosteroid |
- |
- |
- |
- |
013 10件: 13, 42, 43, 44, 45, 66, 84, 96, 97, 222 💬 |
306 |
Cosmofer |
- |
- |
- |
- |
086 3件: 86, 96, 97 💬 |
307 |
Cosmofer 50mg/ml solution for infusion or injection |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
308 |
Cp |
- |
- |
- |
- |
006 6件: 6 , 46, 96, 97, 107, 271 💬 |
309 |
Cp-461 |
- |
- |
- |
- |
096 1件: 96 💬 |
310 |
Cp-690,550 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
311 |
Cp-690,550-10 |
- |
- |
- |
- |
046 5件: 46, 96, 97, 107, 271 💬 |
312 |
Cpsi-2364 |
- |
- |
- |
- |
096 1件: 96 💬 |
313 |
Crohn's disease |
- |
- |
- |
- |
096 1件: 96 💬 |
314 |
Crohns disease exclusion diet + pen |
- |
- |
- |
- |
096 1件: 96 💬 |
315 |
Crown |
- |
- |
- |
- |
096 1件: 96 💬 |
316 |
Ct-p13 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
317 |
Ct-p13 sc (infliximab) |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
318 |
Ctla4ig |
- |
- |
- |
- |
046 4件: 46, 49, 96, 271 💬 |
319 |
Curcuma |
- |
- |
- |
- |
096 1件: 96 💬 |
320 |
Curcuma longa |
Turmeric |
- |
- |
- |
096 2件: 96, 299 💬 |
321 |
Curcuma longa rhizoma |
Turmeric |
- |
- |
- |
096 1件: 96 💬 |
322 |
Curcumin |
Curcumin |
- |
- |
- |
002 11件: 2 , 13, 46, 49, 67, 74, 94, 96, 97, 139, 299 💬 |
323 |
Cx401 |
- |
- |
- |
- |
096 1件: 96 💬 |
324 |
Cx601 |
- |
- |
- |
- |
096 1件: 96 💬 |
325 |
Cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
011 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
326 |
Cyclophosphamide monohydrate |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
013 4件: 13, 60, 96, 256 💬 |
327 |
Cyltezo |
- |
- |
- |
- |
096 1件: 96 💬 |
328 |
Cytochrome p450 (cyp) substrates |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
329 |
Cytoxan |
- |
- |
- |
- |
060 2件: 60, 96 💬 |
330 |
D-cura |
- |
- |
- |
- |
096 1件: 96 💬 |
331 |
D9421-c |
- |
- |
- |
- |
096 1件: 96 💬 |
332 |
D9421-c capsule 3 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
333 |
D9421-c, 15mg |
- |
- |
- |
- |
096 1件: 96 💬 |
334 |
D9421-c, 9mg |
- |
- |
- |
- |
096 1件: 96 💬 |
335 |
Darvadstrocel |
- |
- |
- |
- |
096 1件: 96 💬 |
336 |
Db adalimumab 40 mg eow |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
337 |
Db adalimumab 40 mg ew |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
338 |
Decortin 20 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
339 |
Decortin 5 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
340 |
Dehydroepiandrosterone |
Prasterone |
1件: D08409 D08409 💬 |
AR 3件: AR, ESR1, ESR2 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 5件: 49, 53, 83, 96, 113 💬 |
341 |
Dehydroepiandrosterone [dhea] |
Prasterone |
1件: D08409 D08409 💬 |
AR 3件: AR, ESR1, ESR2 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
096 1件: 96 💬 |
342 |
Dekristol 20.000 ie |
- |
- |
- |
- |
096 1件: 96 💬 |
343 |
Delayed release 6 mercaptopurine |
Mercaptopurine |
2件: D00161 D00161, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 1件: 96 💬 |
344 |
Delayed release 6mp or calcitriol vs. purinethol |
Calcitriol |
1件: D00129 D00129 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 1件: 96 💬 |
345 |
Denosumab |
Denosumab |
1件: D03684 D03684 💬 |
TNFSF11 1件: TNFSF11 💬 |
Breast cancer 7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis |
046 7件: 46, 50, 93, 95, 96, 274, 299 💬 |
346 |
Device: capsule endoscopy |
- |
- |
- |
- |
096 1件: 96 💬 |
347 |
Device: cellulose |
Microcrystalline cellulose |
1件: D00093 D00093 💬 |
- |
- |
096 1件: 96 💬 |
348 |
Device: contrast enhanced ultrasound |
- |
- |
- |
- |
096 1件: 96 💬 |
349 |
Device: endopath from itamar medical - fda approved device. |
- |
- |
- |
- |
096 1件: 96 💬 |
350 |
Device: fluorescence endoscopy and spectroscopy |
- |
- |
- |
- |
096 1件: 96 💬 |
351 |
Device: magnetic resonance enterography (mre) |
- |
- |
- |
- |
096 1件: 96 💬 |
352 |
Device: pma-zeolite |
- |
- |
- |
- |
096 1件: 96 💬 |
353 |
Device: ultrasound elastography |
- |
- |
- |
- |
096 1件: 96 💬 |
354 |
Device: ultrasound imaging |
- |
- |
- |
- |
096 1件: 96 💬 |
355 |
Device: ultrasound vascularity |
- |
- |
- |
- |
096 1件: 96 💬 |
356 |
Dexametasona |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
357 |
Dexamethasone |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
358 |
Dexamethasone sodium phosphate |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
065 3件: 65, 70, 96 💬 |
359 |
Dexamethasone sodium phosphate 250 mg/ 10 ml |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
360 |
Dextran |
Dextran |
1件: D00060 D00060 💬 |
- |
- |
002 5件: 2 , 62, 79, 96, 97 💬 |
361 |
Dextromethorphan |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 11件: 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
362 |
Dextromethorphan 30 mg |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
096 2件: 96, 97 💬 |
363 |
Dhea |
Prasterone |
1件: D08409 D08409 💬 |
AR 3件: AR, ESR1, ESR2 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 3件: 49, 86, 96 💬 |
364 |
Diagnostic test: 18f-fdg and 68ga-fapi pet/ct |
Fludeoxyglucose (18F) |
- |
- |
- |
096 1件: 96 💬 |
365 |
Diagnostic test: serum leucine-rich alpha-2 glycoprotein (lrg) levels |
Leucine |
1件: D00030 D00030 💬 |
- |
- |
096 2件: 96, 97 💬 |
366 |
Diet 1 |
- |
- |
- |
- |
096 1件: 96 💬 |
367 |
Diet 2 |
- |
- |
- |
- |
096 1件: 96 💬 |
368 |
Dietary therapy |
- |
- |
- |
- |
096 1件: 96 💬 |
369 |
Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphtalen-2-ylmethyl]-ammonium chloride mon |
Ammonium chloride |
1件: D01139 D01139 💬 |
- |
- |
096 1件: 96 💬 |
370 |
Diflucan |
Fluconazole |
2件: D00322 D00322, D01429 D01429 💬 |
- |
- |
096 1件: 96 💬 |
371 |
Diphenhydramine |
Diphenhydramine |
6件: D00300 D00300, D00669 D00669, D02419 D02419, D03285 D03285, D03360 D03360, D03854 D03854 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
011 8件: 11, 49, 51, 70, 86, 96, 222, 256 💬 |
372 |
Dlx105 |
- |
- |
- |
- |
096 1件: 96 💬 |
373 |
Doxycycline |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
013 15件: 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 162, 167, 227, 280, 299 💬 |
374 |
Doxycycline hyclate |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
023 3件: 23, 96, 227 💬 |
375 |
E-device |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
376 |
E6011 |
- |
- |
- |
- |
046 3件: 46, 93, 96 💬 |
377 |
E6011 10 mg/kg |
- |
- |
- |
- |
096 1件: 96 💬 |
378 |
E6011 15 mg/kg |
- |
- |
- |
- |
096 1件: 96 💬 |
379 |
E6011 2 mg/kg |
- |
- |
- |
- |
096 1件: 96 💬 |
380 |
E6011 5 mg/kg |
- |
- |
- |
- |
096 1件: 96 💬 |
381 |
Early immunosuppressants (azathioprine, methotrexate) |
Azathioprine |
4件: D00142 D00142, D00238 D00238, D02115 D02115, D03033 D03033 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
096 1件: 96 💬 |
382 |
Eb8018 |
- |
- |
- |
- |
096 1件: 96 💬 |
383 |
Eb8018 (first-in-class fimh blocker) |
- |
- |
- |
- |
096 1件: 96 💬 |
384 |
Een |
- |
- |
- |
- |
096 1件: 96 💬 |
385 |
Een intervention group |
- |
- |
- |
- |
096 1件: 96 💬 |
386 |
Efalizumab |
Efalizumab |
1件: D03959 D03959 💬 |
ITGAL 1件: ITGAL 💬 |
Cell adhesion molecules 12件: Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis |
011 8件: 11, 13, 37, 46, 53, 61, 95, 96 💬 |
387 |
Egg |
Egg |
- |
- |
- |
096 2件: 96, 310 💬 |
388 |
Egg albumen powder |
Egg |
- |
- |
- |
096 1件: 96 💬 |
389 |
Egg white |
Egg |
- |
- |
- |
096 1件: 96 💬 |
390 |
Egg white protein |
Egg |
- |
- |
- |
096 1件: 96 💬 |
391 |
Eicosapentaenoic acid |
Icosapent |
1件: D08061 D08061 💬 |
- |
- |
049 5件: 49, 96, 97, 296, 297 💬 |
392 |
Emea/h/c/000240 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
393 |
Emea/h/c/002778 |
- |
- |
- |
- |
096 1件: 96 💬 |
394 |
Endoxan |
- |
- |
- |
- |
013 7件: 13, 28, 43, 44, 85, 96, 222 💬 |
395 |
Endoxan baxter |
- |
- |
- |
- |
013 3件: 13, 43, 96 💬 |
396 |
Entecavir |
Entecavir |
2件: D04008 D04008, D07896 D07896 💬 |
- |
- |
046 5件: 46, 56, 96, 97, 271 💬 |
397 |
Enteral nutrition |
- |
- |
- |
- |
096 1件: 96 💬 |
398 |
Enteral nutrition. |
- |
- |
- |
- |
096 1件: 96 💬 |
399 |
Entocort |
- |
- |
- |
- |
096 1件: 96 💬 |
400 |
Entocort cr |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
401 |
Entocort® kapseln |
- |
- |
- |
- |
096 1件: 96 💬 |
402 |
Entyvio |
- |
- |
- |
- |
094 3件: 94, 96, 97 💬 |
403 |
Epanova |
- |
- |
- |
- |
096 1件: 96 💬 |
404 |
Epanova™ (omega-3 free fatty acids) |
Omega-3 fatty acids |
- |
- |
- |
096 1件: 96 💬 |
405 |
Epaxal berna (virosomal hepatitis a vaccine) |
Hepatitis A Vaccine |
- |
- |
- |
096 2件: 96, 97 💬 |
406 |
Epinephrine |
Epinephrine |
3件: D00095 D00095, D00996 D00996, D02149 D02149 💬 |
ADRA1A 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 2件: 46, 96 💬 |
407 |
Erb-041 |
- |
- |
- |
- |
046 3件: 46, 96, 226 💬 |
408 |
Ergocalciferol |
Ergocalciferol |
1件: D00187 D00187 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
046 5件: 46, 84, 96, 97, 299 💬 |
409 |
Ery-dex |
- |
- |
- |
- |
096 1件: 96 💬 |
410 |
Erythropoietin |
Erythropoietin |
1件: D03231 D03231 💬 |
EPOR 1件: EPOR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 9件: 2 , 6 , 13, 18, 22, 47, 70, 95, 96 💬 |
411 |
Eskazole |
Albendazole |
1件: D00134 D00134 💬 |
- |
- |
096 1件: 96 💬 |
412 |
Etiprednol dicloacetate |
Etiprednol dicloacetate |
1件: D04100 D04100 💬 |
- |
- |
096 1件: 96 💬 |
413 |
Etrasimod |
Etrasimod |
1件: D10930 D10930 💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
096 2件: 96, 97 💬 |
414 |
Etrasimod l-arginine |
Arginine |
2件: D02982 D02982, D10930 D10930 💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
096 2件: 96, 97 💬 |
415 |
Etrolizumab |
Etrolizumab |
1件: D09901 D09901 💬 |
ITGB7 1件: ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 11件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer |
096 2件: 96, 97 💬 |
416 |
Eu/1/03/268/002 |
- |
- |
- |
- |
096 1件: 96 💬 |
417 |
Eu/1/99/116/003 |
- |
- |
- |
- |
096 1件: 96 💬 |
418 |
Evaluation of biological predictive factors of clinical response to ustekinumab |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 1件: 96 💬 |
419 |
Everolimus |
Everolimus |
1件: D02714 D02714 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
034 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬 |
420 |
Exclusive enteral nutrition |
- |
- |
- |
- |
096 1件: 96 💬 |
421 |
Exclusive enteral nutrition therapy |
- |
- |
- |
- |
096 1件: 96 💬 |
422 |
Expanded allogenic adipose-derived adult stem cells |
- |
- |
- |
- |
096 1件: 96 💬 |
423 |
Expanded autologous adipose-derived adult stem cells (eascs) |
- |
- |
- |
- |
096 1件: 96 💬 |
424 |
Expanded human allogenic mesemchymal adult stem cells extracted from adipose tissue (eascs) |
- |
- |
- |
- |
096 1件: 96 💬 |
425 |
Expanded human allogenic mesenchymal adult stem cells extractd from adipose tissue (eascs) |
- |
- |
- |
- |
096 1件: 96 💬 |
426 |
Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue |
- |
- |
- |
- |
096 1件: 96 💬 |
427 |
Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eascs |
- |
- |
- |
- |
096 1件: 96 💬 |
428 |
Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eascs) |
- |
- |
- |
- |
096 1件: 96 💬 |
429 |
Faecal microbiota transplantation |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
430 |
Fe 999301 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
431 |
Fecal microbial transplant |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
432 |
Fecal microbial transplantation |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
433 |
Fecal microbiota |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
434 |
Fecal microbiota transplant |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
435 |
Fecal microbiota transplant (fmt) |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
436 |
Fecal microbiota transplantation |
- |
- |
- |
- |
002 5件: 2 , 66, 94, 96, 97 💬 |
437 |
Fecal microbiota transplantation (fmt) |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
438 |
Ferric carboxy maltose |
Maltose |
1件: D00044 D00044 💬 |
- |
- |
096 1件: 96 💬 |
439 |
Ferric carboxymaltose |
Ferric carboxymaltose |
1件: D08920 D08920 💬 |
- |
- |
086 4件: 86, 96, 97, 299 💬 |
440 |
Ferric maltol |
Ferric maltol |
1件: D10833 D10833 💬 |
- |
- |
096 1件: 96 💬 |
441 |
Ferrous sulphate |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
442 |
Ffp104 |
- |
- |
- |
- |
093 2件: 93, 96 💬 |
443 |
Filgotinib |
Filgotinib |
1件: D10871 D10871 💬 |
JAK1 1件: JAK1 💬 |
Coronavirus disease - COVID-19 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 6件: 46, 53, 96, 97, 222, 271 💬 |
444 |
Filgrastim |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 27件: 2 , 6 , 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
445 |
Fish oil |
Fish oil |
- |
- |
- |
013 7件: 13, 46, 49, 66, 96, 260, 299 💬 |
446 |
Fitc-adalimumab |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
447 |
Flagyl |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
448 |
Flixabi |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
449 |
Fluconazole |
Fluconazole |
2件: D00322 D00322, D01429 D01429 💬 |
- |
- |
096 2件: 96, 225 💬 |
450 |
Fludarabine |
Fludarabine |
2件: D01907 D01907, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 💬 |
451 |
Fludarabine phosphate |
Fludarabine |
2件: D01907 D01907, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
028 11件: 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285 💬 |
452 |
Fmt |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
453 |
Folatescan (technetium tc 99mec20) |
- |
- |
- |
- |
013 4件: 13, 46, 49, 96 💬 |
454 |
Fos |
- |
- |
- |
- |
066 2件: 66, 96 💬 |
455 |
Fosfato sodico de dexametasona |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
456 |
Fosfomycin |
Fosfomycin |
4件: D00925 D00925, D02187 D02187, D02188 D02188, D04253 D04253 💬 |
- |
- |
096 2件: 96, 97 💬 |
457 |
Fully humanised, recombinant monoclonal antibody (igg1) |
- |
- |
- |
- |
096 1件: 96 💬 |
458 |
G-csf |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 16件: 2 , 6 , 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬 |
459 |
G321605 |
- |
- |
- |
- |
085 3件: 85, 96, 97 💬 |
460 |
Ged-0301 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
461 |
Genetic: genetic analysis |
- |
- |
- |
- |
096 1件: 96 💬 |
462 |
Genetic: tpmt genotyping |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
463 |
Glatiramer |
Glatiramer |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
002 4件: 2 , 13, 96, 156 💬 |
464 |
Glatiramer acetate |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 3件: 13, 96, 156 💬 |
465 |
Glpg0634 |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
466 |
Glpg1205 |
- |
- |
- |
- |
085 3件: 85, 96, 97 💬 |
467 |
Glucose |
Dextrose, unspecified form |
- |
- |
- |
002 15件: 2 , 6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬 |
468 |
Glutamine |
L-Glutamine |
1件: D00015 D00015 💬 |
- |
- |
087 7件: 87, 89, 96, 97, 113, 245, 299 💬 |
469 |
Gold |
Gold |
- |
- |
- |
002 38件: 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
470 |
Golimumab |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 6件: 46, 56, 84, 96, 97, 271 💬 |
471 |
Green tea |
Green tea leaf |
1件: D06903 D06903 💬 |
- |
- |
006 5件: 6 , 17, 28, 46, 96 💬 |
472 |
Group 2 ustekinumab 130 mg |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 1件: 96 💬 |
473 |
Group 3: ustekinumab approximately 6 mg/kg |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 1件: 96 💬 |
474 |
Growth hormone |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 12件: 2 , 13, 19, 46, 78, 96, 187, 191, 193, 195, 265, 299 💬 |
475 |
Gs-5745 |
GS-5745 |
- |
- |
- |
046 4件: 46, 96, 97, 299 💬 |
476 |
Gs-6034 |
- |
- |
- |
- |
046 4件: 46, 53, 96, 97 💬 |
477 |
Gsk1070806 |
- |
- |
- |
- |
056 2件: 56, 96 💬 |
478 |
Gsk1605786 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
479 |
Gsk1605786 500 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
480 |
Gsk1605786 capsule |
- |
- |
- |
- |
096 1件: 96 💬 |
481 |
Gsk1605786 chemocentryx: formulation a |
- |
- |
- |
- |
096 1件: 96 💬 |
482 |
Gsk1605786 gsk direct-fill: formulation c |
- |
- |
- |
- |
096 1件: 96 💬 |
483 |
Gsk1605786 gsk modified-process: formulation d |
- |
- |
- |
- |
096 1件: 96 💬 |
484 |
Gsk1605786 gsk tablet: formulation e |
- |
- |
- |
- |
096 1件: 96 💬 |
485 |
Gsk1605786 gsk: formulation b |
- |
- |
- |
- |
096 1件: 96 💬 |
486 |
Gsk1605786a |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
487 |
Gsk2330811 |
- |
- |
- |
- |
051 2件: 51, 96 💬 |
488 |
Guselkumab |
Guselkumab |
1件: D10438 D10438 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
037 4件: 37, 41, 96, 97 💬 |
489 |
Guselkumab dose 1 |
Guselkumab |
1件: D10438 D10438 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 2件: 96, 97 💬 |
490 |
Guselkumab dose 2 |
Guselkumab |
1件: D10438 D10438 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 2件: 96, 97 💬 |
491 |
Guselkumab dose 3 |
Guselkumab |
1件: D10438 D10438 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
492 |
Guselkumab dose 4 |
Guselkumab |
1件: D10438 D10438 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
493 |
Guselkumab dose 5 |
Guselkumab |
1件: D10438 D10438 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
494 |
Hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 12件: 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285 💬 |
495 |
Hepatitis a vaccine |
Hepatitis A Vaccine |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
496 |
Herpes zoster vaccine |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
497 |
Hextend |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
498 |
High dose tso |
- |
- |
- |
- |
096 1件: 96 💬 |
499 |
High oligosaccharide group |
- |
- |
- |
- |
096 1件: 96 💬 |
500 |
High-dose cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
096 1件: 96 💬 |
501 |
Hmpl-004 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
502 |
Hmpl004-6599 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
503 |
Hulio |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
504 |
Hum291 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
505 |
Human albumin |
Albumin human |
2件: D02792 D02792, D05424 D05424 💬 |
- |
- |
002 2件: 2 , 96 💬 |
506 |
Human albumin as macroaggregates |
Albumin human |
2件: D02792 D02792, D05424 D05424 💬 |
- |
- |
096 1件: 96 💬 |
507 |
Human anti-il-12 antibody |
- |
- |
- |
- |
096 1件: 96 💬 |
508 |
Human anti-ip10 monoclonal antibody |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
509 |
Human insulin |
Insulin human |
2件: D00085 D00085, D03230 D03230 💬 |
INSR 1件: INSR 💬 |
AMPK signaling pathway 22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway |
096 2件: 96, 156 💬 |
510 |
Human monoclonal antibody (cnto 1275) to interleukin 12p-40 |
- |
- |
- |
- |
096 1件: 96 💬 |
511 |
Human placenta-derived cells pda001 intravenous infusion |
- |
- |
- |
- |
096 1件: 96 💬 |
512 |
Human plasma for fractionation |
- |
- |
- |
- |
096 1件: 96 💬 |
513 |
Humira |
- |
- |
- |
- |
046 7件: 46, 84, 96, 97, 160, 269, 271 💬 |
514 |
Humira (adalimumab original) |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
515 |
Humira (adalimumab) |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 2件: 46, 96 💬 |
516 |
Humira 20 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
096 1件: 96 💬 |
517 |
Humira 40 mg injekcní roztok v predplnené injekcní stríkacce |
- |
- |
- |
- |
096 1件: 96 💬 |
518 |
Humira 40 mg solución inyectable en jeringa precargada |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
519 |
Humira 40 mg solution for injection in pre-filled pen |
- |
- |
- |
- |
096 1件: 96 💬 |
520 |
Humira 40 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
046 3件: |